Biote (BTMD) vs Cryo-Cell International (CCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cryo-Cell International (CCEL) has outperformed Biote (BTMD) over the past year, losing 6.9% versus a loss of 59.2%. Over five years, CCEL leads with a -68.3% price change compared with -88.0% for BTMD. Biote is the larger company by market cap ($39.7 million vs $33.6 million), about 1.2 times the size.
On valuation, Biote trades at a lower forward P/E (2.6x vs 208.5x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | CCEL |
|---|---|---|
| Share price | $1.17 | $4.17 |
| Market cap | $39.66M | $33.62M |
| 1-day change | +5.41% | +6.65% |
| YTD return | -55.00% | +21.22% |
| 1-year return | -59.23% | -6.92% |
| 5-year return | -88.02% | -68.29% |
| P/E ratio (TTM) | 8.36 | — |
| Forward P/E | 2.60 | 208.50 |
| EPS (TTM) | $0.14 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.26 | $4.90 |
| 52-week low | $1.06 | $2.72 |
| Distance from 52-week high | -64.11% | -14.90% |
| Analyst consensus | none | — |
| Avg. price target upside | +123.08% | — |
| Average volume | 230.14K | 24.02K |
| Shares outstanding | 28.68M | 8.06M |
| Employees | 223 | 72 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CCEL has outperformed BTMD by 52.3 percentage points over the past year.
About Biote
BTMD stock →biote Corp. operates in practice-building business within the hormone optimization space.
Healthcare · Medical Care Facilities · 223 employees
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Healthcare · Medical Care Facilities · 72 employees
BTMD vs CCEL FAQ
Which is bigger, Biote or Cryo-Cell International?
Biote (BTMD) is larger, with a market capitalization of $39.66M compared with $33.62M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, BTMD or CCEL?
CCEL returned -6.92% over the past 12 months, compared with -59.23% for BTMD (price return, excluding dividends). Past performance does not predict future results.
Are Biote and Cryo-Cell International in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.